IGF-1 Genetics and Growth Hormone Axis Response

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on Peptides & GLP-1. Browse all Peptides & GLP-1 education

Growth hormone doesn’t act on muscle directly. It sends a message — and that message is IGF-1. When growth hormone pulses out of the pituitary, the liver reads that signal and produces insulin-like growth factor 1, which then travels through the bloodstream to muscle, bone, and connective tissue to trigger anabolic adaptation. The strength of that downstream signal — how much IGF-1 your body produces and how sensitively your cells respond to it — is shaped in part by your IGF1 genotype. The Precision Peptide Genetic Test analyzes IGF1 variants as one of 15 Muscle Growth insights across 14 pathways, 49 peptides, and 150+ genetic insights.

The Growth Hormone Axis: How IGF-1 Fits In

The growth hormone axis is a two-stage signaling system. The first stage is pulsatile GH release from the anterior pituitary — triggered by sleep, exercise, fasting, and the ghrelin receptor pathway. The second stage is hepatic IGF-1 production: the liver responds to circulating GH by synthesizing and secreting IGF-1, which then acts as the primary anabolic messenger throughout the body.

At the muscle level, IGF-1 binds to its receptor and activates the PI3K/Akt/mTOR pathway — the central route for protein synthesis initiation and muscle fiber growth. It also stimulates muscle satellite cells: the stem-cell-like precursors that fuse into existing fibers to add myonuclei and enable hypertrophy beyond the myonuclear domain limit. Beyond circulating IGF-1, muscle tissue itself produces a local variant — sometimes called mechano-growth factor — in response to mechanical loading. Both systemic and local IGF-1 activity are influenced by the underlying IGF1 gene architecture.

IGF1 Variants and What They Measure

The most studied functional variant in the IGF1 gene is a cytosine-adenine (CA) microsatellite repeat polymorphism in the promoter region. The 192-base-pair allele — containing 19 CA repeats — is associated with higher circulating IGF-1 levels compared to non-192bp allele carriers. This matters because basal IGF-1 production level is a significant predictor of anabolic signaling capacity at rest and in response to training or growth hormone axis stimulation.

Additional SNPs including rs35767 and rs2288377 have been studied for their influence on IGF1 transcription and circulating IGF-1 concentration. The practical finding across the literature is consistent: IGF1 genotype contributes meaningfully to baseline and stimulus-driven IGF-1 levels, which in turn shape the anabolic environment available to muscle tissue after training or growth hormone axis pathway engagement.

What Your IGF1 Profile Means for Anabolic Response

Individuals with genotypes associated with higher baseline IGF-1 production operate with a stronger resting anabolic signal — faster baseline protein synthesis, more responsive satellite cell activation after training, and quicker recovery between sessions. That doesn’t mean outcomes are predetermined. Training stimulus, sleep quality, nutrition adequacy, and recovery management all influence how much of that genetic ceiling gets realized.

For individuals whose IGF1 genotype is associated with lower baseline production, the same anabolic potential exists — but the pathway runs at a lower default amplitude. This cohort often benefits most from recovery optimization: prioritizing deep sleep (the primary driver of endogenous GH pulsatility), managing training volume to avoid overreaching, and ensuring micronutrient status — particularly zinc and vitamin D — supports the GH-to-IGF-1 conversion pathway. Genetics as a guide, not a guarantee: knowing where your baseline sits helps you build a protocol that works with your biology rather than assuming a generic ceiling.

IGF-1 and Growth Hormone Axis Pathways

Growth hormone axis peptide protocols are designed to engage the upstream triggers of IGF-1 production — stimulating GH release through pathways involving the ghrelin receptor (GHSR) and the GH-releasing hormone system. The degree to which that upstream stimulation translates into downstream anabolic effect depends significantly on your IGF1 genotype. Individuals with higher-production genotypes may express a more robust downstream signal from equivalent upstream stimulation. Those with lower-production genotypes may achieve the same pathway engagement but with a proportionally modulated anabolic output.

This is why reading IGF1 findings alongside GHSR and GHR results produces the most actionable picture. GHSR governs GH release pulsatility; GHR determines receptor sensitivity to the GH signal; IGF1 determines how forcefully the liver and muscle tissue respond. All three are in the Precision Peptide Genetic Test panel. Together, they map the complete growth hormone axis from first signal to final anabolic output.

The Full Muscle Growth Genetic Panel

IGF1 is the anabolic signaling anchor of the Precision Peptide Genetic Test’s 15 Muscle Growth insights. The other genes in the panel target the mechanisms that determine what your body does with that signal once it arrives:

ACTN3 (R577X) — fast-twitch fiber composition; determines how aggressively muscle fibers hypertrophy in response to anabolic signals.

MSTN (myostatin) — the negative regulator; determines how actively your body suppresses hypertrophy at the cellular level.

GHSR — the ghrelin receptor; governs GH pulse frequency and amplitude upstream of IGF-1 production.

GHR — growth hormone receptor; determines cellular sensitivity to the GH signal that triggers hepatic IGF-1 synthesis.

VDR — vitamin D receptor; influences muscle contractility and intersects with anabolic signaling at the downstream level.

ACE — the I/D variant determining endurance-versus-power physiology, with training response implications that compound IGF-1-driven hypertrophy differently by genotype.

IL-6 — post-exercise inflammation regulator; governs how fast tissue repair activates after the training stimulus that triggers local IGF-1 production.

Beyond the Muscle Growth pathway, 12 Energy Metabolism insights, 9 Tissue Repair insights, and 17 Longevity & Aging insights all intersect with the IGF-1 axis — particularly through the mTOR and FOXO3 pathways, where anabolic signaling and cellular longevity regulation trade off against each other.

The Precision Peptide Genetic Test analyzes how your genes influence muscle growth pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to map your complete growth hormone axis genetic profile? Take the Precision Peptide Genetic Test

Frequently Asked Questions About IGF-1 Genetics and Muscle Growth

What does the IGF1 gene reveal about muscle growth and recovery?

IGF1 encodes the primary downstream messenger of growth hormone signaling. Variants in IGF1 influence how much IGF-1 your liver produces in response to GH stimulation — affecting anabolic signaling capacity, satellite cell activation, and tissue repair rate. The Precision Peptide Genetic Test reports IGF1 as part of 15 Muscle Growth insights and 150+ genetic insights.

How does IGF1 genotype affect growth hormone axis peptide protocols?

IGF1 genotype influences the signal strength your body produces in response to GH axis activation. Genotypes associated with higher IGF-1 production may express anabolic pathway signals more robustly. Knowing your IGF1 profile helps you and your healthcare provider contextualize realistic expectations for any growth hormone axis protocol. Results inform conversations — not prescriptions.

What other genes are tested alongside IGF1 in the muscle growth panel?

The Precision Peptide Genetic Test analyzes 15 Muscle Growth insights — including ACTN3 (fiber type), MSTN (myostatin ceiling), GHSR (ghrelin receptor and GH release), GHR (growth hormone receptor), VDR (vitamin D and muscle), ACE (power vs endurance), and IL-6 (inflammation and recovery). IGF1 is the anabolic signaling anchor of a multi-gene panel.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.